SCHEMBL23148262

SCHEMBL23148262

Clc1cnc2sc3ccc(Br)cc3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.36
MIF P14174 1/20 0.36
EPM2A O95278 1/20 0.35
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPN22 Q9Y2R2 1/20 0.35
CHUK O15111 1/20 0.34
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPC1 O15118 2/20 0.33
CLK1 P49759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30382079 1.00 IDO1 (0.36) IDO1MIFEPM2APTPN2PTPN1
SCHEMBL16693321 0.86 EPM2A (0.39) IDO1EPM2APTPN2PTPN1PTPN22
SCHEMBL1741605 0.78 GPR3 (0.45) KDM4EMEN1KMT2AALDH1A1NPC1
SCHEMBL29450780 0.77 KDM4E (0.50) IDO1MIFEPM2APTPN2PTPN1
SCHEMBL15989733 0.77 KDM4E (0.50) IDO1MIFEPM2APTPN2PTPN1
SCHEMBL16693330 0.73 CLK1 (0.42) EPM2APTPN2PTPN1PTPN22CHUK
SCHEMBL1741599 0.73 EPM2A (0.40) IDO1MIFEPM2APTPN2PTPN1
SCHEMBL29432245 0.72 EPM2A (0.53) IDO1MIFEPM2APTPN2PTPN1
SCHEMBL216673 0.72 EPM2A (0.53) IDO1MIFEPM2APTPN2PTPN1
SCHEMBL16685601 0.71 GPR3 (0.45) IDO1KDM4EALDH1A1L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11647669-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-09 US disclosed
US-11647669-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-09 US disclosed
US-11647669-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-09 US disclosed
US-20210098720-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11647669-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 IDO1 799/4885MIF 3618/4885EPM2A 1374/4885
US-20210098720-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 IDO1 799/4885MIF 3618/4885EPM2A 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.